ChampionX Co. (NASDAQ:CHX) Shares Sold by Natixis Advisors L.P.

Natixis Advisors L.P. trimmed its holdings in shares of ChampionX Co. (NASDAQ:CHX) by 17.8% in the 4th quarter, HoldingsChannel.com reports. The fund owned 337,356 shares of the company’s stock after selling 73,041 shares during the quarter. Natixis Advisors L.P.’s holdings in ChampionX were worth $9,853,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of the business. Benjamin Edwards Inc. lifted its stake in ChampionX by 14.6% during the 4th quarter. Benjamin Edwards Inc. now owns 7,298 shares of the company’s stock valued at $213,000 after acquiring an additional 927 shares during the period. Fisher Asset Management LLC lifted its stake in ChampionX by 7.2% during the 4th quarter. Fisher Asset Management LLC now owns 365,690 shares of the company’s stock valued at $10,682,000 after acquiring an additional 24,554 shares during the period. GAMMA Investing LLC acquired a new stake in ChampionX during the 4th quarter valued at approximately $26,000. Jennison Associates LLC lifted its stake in shares of ChampionX by 17.7% in the 4th quarter. Jennison Associates LLC now owns 25,053 shares of the company’s stock valued at $732,000 after purchasing an additional 3,765 shares during the period. Finally, Federated Hermes Inc. lifted its stake in shares of ChampionX by 24.2% in the 4th quarter. Federated Hermes Inc. now owns 610,656 shares of the company’s stock valued at $17,837,000 after purchasing an additional 119,003 shares during the period. 98.99% of the stock is currently owned by institutional investors and hedge funds.

ChampionX Stock Performance

NASDAQ:CHX opened at $33.88 on Thursday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.16 and a current ratio of 1.83. The company has a fifty day moving average of $34.69 and a two-hundred day moving average of $31.13. The stock has a market capitalization of $6.45 billion, a PE ratio of 18.41, a P/E/G ratio of 1.06 and a beta of 2.45. ChampionX Co. has a fifty-two week low of $24.98 and a fifty-two week high of $39.95.

ChampionX (NASDAQ:CHX) last posted its quarterly earnings data on Wednesday, April 24th. The company reported $0.50 earnings per share for the quarter, topping analysts’ consensus estimates of $0.40 by $0.10. The company had revenue of $922.14 million during the quarter, compared to analysts’ expectations of $922.13 million. ChampionX had a net margin of 9.74% and a return on equity of 21.42%. As a group, research analysts forecast that ChampionX Co. will post 1.95 earnings per share for the current fiscal year.

ChampionX Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, April 26th. Stockholders of record on Friday, April 5th were issued a dividend of $0.095 per share. This is a positive change from ChampionX’s previous quarterly dividend of $0.09. The ex-dividend date of this dividend was Thursday, April 4th. This represents a $0.38 dividend on an annualized basis and a dividend yield of 1.12%. ChampionX’s dividend payout ratio is presently 20.65%.

Insider Transactions at ChampionX

In other news, insider William Jr. O’dell sold 27,178 shares of the company’s stock in a transaction on Thursday, March 28th. The shares were sold at an average price of $36.00, for a total transaction of $978,408.00. Following the completion of the sale, the insider now owns 57,748 shares of the company’s stock, valued at $2,078,928. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 1.38% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the stock. Piper Sandler boosted their target price on shares of ChampionX from $32.00 to $40.00 and gave the company a “neutral” rating in a research note on Monday, April 8th. Citigroup boosted their target price on shares of ChampionX from $39.00 to $40.00 and gave the company a “buy” rating in a research note on Wednesday, March 27th. Finally, Barclays boosted their target price on shares of ChampionX from $39.00 to $51.00 and gave the company an “overweight” rating in a research note on Thursday, April 4th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $40.33.

ChampionX Company Profile

ChampionX Corporation provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide. The company operates through four segments: Production Chemical Technologies, Production & Automation Technologies, Drilling Technologies, and Reservoir Chemical Technologies.